Delivery Order SPE2DB22D2006-SPE2DB25FW2RY
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 18, 2025, for the supply of Entresto 49 mg-51 mg tablets (180-count supply) with a ceiling value of $51,539.65. This is a firm fixed-price delivery order with an ultimate completion date of July 21, 2025, and represents a competitively awarded contract with no set-aside designation. The work will be performed in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $2,346.88 to AmerisourceBergen Drug Corp for the supply of Entresto 97 mg-103 mg tablets (180-count) on July 25, 2025, with an ultimate completion date of July 28, 2025. This firm fixed-price delivery order represents a non-competitive award under the company's broader indefinite delivery contract (IDC) with DLA Troop Support Medical. The pharmaceutical product will be delivered to the company's corporate office location in...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $17,962.22 on August 4, 2025, for the supply of Entresto 24 mg-26 mg tablets (180-count). This competitively awarded, firm fixed-price delivery order is non-set-aside and will be performed at the company's corporate office location in Conshohocken, Pennsylvania, with an ultimate completion date of August 5, 2025. The delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract...
- The Defense Logistics Agency awarded a $3,689.75 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Entresto 24 mg-26 mg tablets (60-count supply) on July 18, 2025, with an ultimate completion date of July 21, 2025. This non-competitive delivery order was placed against AmerisourceBergen's substantial Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. The order will be fulfilled at...
- The Defense Logistics Agency (DLA) Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp for $33,369.67 to supply Entresto 24 mg-26 mg tablets (180-count units). This non-competitive, firm fixed price delivery order was awarded on August 18, 2025, with an ultimate completion date of August 19, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The order represents a standard pharmaceutical supply transaction under...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $6,188.82 to AmerisourceBergen Drug Corp for the supply of Entresto 24 mg-26 mg tablets (60-count units) on July 25, 2025, with completion scheduled for July 28, 2025. This firm fixed-price delivery order was competitively awarded without set-aside provisions and represents a continuation of pharmaceutical procurement through DLA's existing contract vehicle. The place of performance is AmerisourceBergen's corporate office...
- The Defense Logistics Agency awarded a $5,013.67 delivery order to AmerisourceBergen Drug Corp on July 24, 2025, for the supply of Entresto 49 mg-51 mg tablets (180-count). This is a firm fixed-price, competitively awarded contract with no set-aside designation. The order will be fulfilled from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, with an ultimate completion date of July 25, 2025. This delivery order is issued under AmerisourceBergen's larger Indefinite...
- The Defense Logistics Agency awarded a $14,010.67 firm fixed-price delivery order to AmerisourceBergen Drug Corp on July 30, 2025, for the supply of Entresto 24 mg-26 mg tablets (60-count units). The contract, which is not set-aside and was competitively awarded, has an ultimate completion date of July 31, 2025. AmerisourceBergen Drug Corp will fulfill this order from its corporate office location in Conshohocken, Pennsylvania, where the company serves as a major pharmaceutical distributor for...
- The Defense Logistics Agency awarded a $22,834.45 delivery order to AmerisourceBergen Drug Corp on August 4, 2025, for the supply of Entresto 49 mg-51 mg tablets (180 count). This firm fixed-price contract, with an ultimate completion date of August 5, 2025, represents a non-set-aside competitive award utilizing the company's existing indefinite delivery contract vehicle with DLA. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, serves as the place of performance for this...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a $3,214.04 firm fixed price delivery order for Entresto 24 mg-26 mg tablets (60-count) on July 29, 2025, with completion scheduled for July 30, 2025. This non-set-aside contract represents a single delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), which is valued at $999,999,999.00 and extends through December 2026. The pharmaceutical product will be...
- SPE2DB22D2006Indefinite Delivery Contract
- SPE2DB22D2006-SPE2DB25FW2RYDelivery Order
The Defense Logistics Agency (DLA) awarded AmerisourceBergen Drug Corp a delivery order valued at $83,524.51 on July 22, 2025, for the supply of Entresto 24 mg-26 mg tablets (180-count units). This is a firm fixed price, competitively awarded contract with no set-aside designation and an ultimate completion date of July 23, 2025. AmerisourceBergen will perform the delivery order from its corporate office location in Conshohocken, Pennsylvania, where the company maintains its headquarters as a major pharmaceutical distributor and healthcare solutions provider. This delivery order is issued under AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which carries a maximum value of $999,999,999 and extends through December 2026. The parent IDC serves as a comprehensive global pharmaceutical support vehicle enabling AmerisourceBergen to supply a broad range of pharmaceutical products and medical supplies to support military healthcare programs worldwide. Through this contract vehicle, the company provides critical medical commodities including specialty medications, brand-name and generic drugs, and vaccines to customers including the Defense Health Agency and U.S. Coast Guard, positioning it as a key vendor within the federal medical supply chain supporting defense and veteran healthcare systems.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $83.5k | 7/22/25 |